Price T Rowe Associates Inc AVADEL PHARMACEUTICALS PLC Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025
Number of Shares
44,743
Previous 40,350 10.89%
Holding current value
$396,000
Previous $316,000 25.32%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
4,393 Added 10.89%
44,743 $396,000
Q1 2025

May 14, 2025
BUY
N/A
3,677 Added 10.03%
40,350 $316,000
Q4 2024

Feb 14, 2025
BUY
N/A
6,445 Added 21.32%
36,673 $386,000
Q3 2024

Nov 14, 2024
BUY
N/A
837 Added 2.85%
30,228 $397,000
Q2 2024

Aug 14, 2024
BUY
N/A
29,391 New
29,391 $0
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email